Nine Months to Progression Using Fourth-Line Liposomally Encapsulated Paclitaxel against Hepatocellular Carcinoma

Publisher: Karger

E-ISSN: 1421-9794|54|4|309-314

ISSN: 0009-3157

Source: Chemotherapy, Vol.54, Iss.4, 2008-08, pp. : 309-314

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content